Revenue
$0
Fiscal year ended 2026-06-30Operating income
-$22.56K
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30Valuation, from the filing
| Public float | $3.24M | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float per share | $0.04 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today.
How this compares in its industry
Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| Current ratio | 6.72x | 85th |
Nu-Med Plus, Inc. (NUMD) reported revenue of $0 and net income of $19.67K for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Nu-Med Plus, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | -$22.56K | -$13.15K | -$10.42K | -$18.70K | -$356.75K | -$491.16K | -$449.76K | -$904.45K | -$149.31K | -$205.70K |
| Net income | $19.67K | -$15.88K | -$11.66K | -$19.93K | -$356.75K | -$493.37K | -$453.82K | -$908.47K | -$153.33K | -$209.87K |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 83.55M | shares 83.55M | shares 83.55M | shares 83.55M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Pretax income | $19.67K | Unavailable | -$11.66K | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | $0 | $0 | $0 | Unavailable | $0 | $0 | $0 | $0 | $0 | $0 |
| Diluted EPS | $0.00 | Unavailable | $0.00 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0.00 | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $8.07K | $4.83K | $5.47K | $5.70K | $7.83K | $6.57K | $13.71K | $29.58K | $8.40K | $16.11K |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | $139.26K | $188.51K | $31.50K | $6.11K | $18.33K | $7.08K |
| Total assets | $12.91K | $7.18K | Unavailable | Unavailable | $285.01K | $557.14K | $649.56K | $852.24K | $47.22K | $45.78K |
| Current assets | $12.91K | $7.18K | Unavailable | Unavailable | $271.04K | $537.52K | $624.30K | $832.76K | $21.47K | $13.96K |
| Total liabilities | $280.40K | $294.34K | Unavailable | Unavailable | $94.06K | $89.43K | $427.89K | $440.65K | $414.55K | $416.21K |
| Current liabilities | $280.40K | $294.34K | Unavailable | Unavailable | $84.67K | $80.05K | $418.50K | $431.27K | $414.55K | $416.21K |
| Total equity incl. NCI | -$267.49K | -$287.16K | -$246.69K | -$235.03K | $190.96K | $467.70K | $221.68K | $411.59K | -$367.33K | -$370.43K |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | $0 | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $33.91K | $43.11K | Unavailable | Unavailable | $12.64K | $26.05K | $30.11K | $58.05K | $33.59K | $39.82K |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.12K | -$6.38K | -$1.51K | $0 | -$79.24K | -$71.25K | -$101.02K | -$147.34K | -$95.19K | -$124.66K |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 |
| Investing cash flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing cash flow | $0 | $10.00K | $0 | $0 | $30.00K | $228.26K | $126.41K | $135.12K | $106.44K | $89.91K |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | -$49.24K | $157.01K | $25.39K | -$12.22K | $11.25K | -$34.76K |
| Stock-based compensation | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $961.15K | Unavailable | Unavailable | Unavailable | -$156.25K |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | $2.65K | $2.65K | $3.05K | $3.05K | $3.05K | $3.04K |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current ratio | 0.05x | 0.02x | Unavailable | Unavailable | 3.20x | 6.72x | 1.49x | 1.93x | 0.05x | 0.03x |
| Revenue YoY growth | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 0.0% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NUMD in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-K · Filed 2025-03-31View SEC filing
10-Q · Filed 2024-11-14View SEC filing
10-Q · Filed 2024-05-15View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.